A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published in Nature Communications.

Patients' electronic health records convey crucial information. The application of natural language processing techniques to these records may be an effective means of extracting information that may improve clinical decision making, clinical documentation and billing, disease prediction and the detection of adverse drug reactions.

Researchers have developed a tool to identify security and privacy risks associated with COVID-19 contact tracing apps.

COVIDGuardian, the first automated security and privacy assessment tool, tests contact tracing apps for potential threats such as malware, embedded trackers and private information leakage.

Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of paediatric brain tumours a UK-based multi-centre study, including WMG at the University of Warwick has found. This means that the tumour can be characterised and treated more efficiently.

The largest cause of death from cancer in children are brain tumours in a particular part of the brain, called the posterior fossa.

USC researchers have developed a new method to counter emergent mutations of the coronavirus and hasten vaccine development to stop the pathogen responsible for killing thousands of people and ruining the economy.

Using artificial intelligence (AI), the research team at the USC Viterbi School of Engineering developed a method to speed the analysis of vaccines and zero in on the best potential preventive medical therapy.

How much personal information can our phone apps gather through location tracking? To answer this question, two researchers - Mirco Musolesi (University of Bologna, Italy) and Benjamin Baron (University College London, UK) - carried out a field study using an app specifically developed for this research.

When the COVID-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare. "Making new drugs takes forever," says Caroline Uhler, a computational biologist in MIT's Department of Electrical Engineering and Computer Science and the Institute for Data, Systems and Society, and an associate member of the Broad Institute of MIT and Harvard.